Vividion Therapeutics, Inc. Email Format

Biotechnology ResearchCalifornia, United States201-500 Employees

Vividion Therapeutics, Inc. is a San Diego, California-based biotechnology company in the biotechnology research industry that develops highly selective small molecule medicines for proteins traditionally difficult to drug. The company maintains a broad, diversified pipeline of selective small molecule therapeutics for disease-causing targets in oncology and immunology, built on a platform developed by chemical biology and synthetic chemistry experts from The Scripps Research Institute. Vividion is a clinical-stage biotechnology company and a wholly owned subsidiary of Bayer AG. The organization employs between 201 and 500 people. One program, VVD-214, is a Werner helicase covalent inhibitor in development with exclusive worldwide rights to develop and commercialize.

Sign up for free to view info

Company overview Employee directory